AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2019
Aug 16, 2019
10216_dirs_2019-08-16_46e78edd-78c2-4a28-a2b9-c3b4247ecd23.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2019-08-15
Reporting Person: PETERS WILLIAM J (CFO, SVP & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-15 | Common Stock | S | 4942 | $21.00 | Disposed | 82453 | Direct |
Footnotes
F1: Includes 1,056 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2019.
More from Amphastar Pharmaceuticals, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Investor Presentation
2026
Jun 3
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17